My issue is the share price imbalance with the distribution. Also, if they’re waiting for FINRA and they can’t close until an approval, SNTX will likely bleed slow while we wait. Seen it many times. OTC is impatient, so there may be a buying opportunity lower later. IMO, GLTU
Market Data 
Markets 
